Cargando…

Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling

The Janus kinase-signal transducer and activator of transcription protein (JAK-STAT) pathway mediates essential biological functions from immune responses to haematopoiesis. Deregulated JAK-STAT signaling causes myeloproliferative neoplasms, leukaemia, and lymphomas, as well as autoimmune diseases....

Descripción completa

Detalles Bibliográficos
Autores principales: Raivola, Juuli, Haikarainen, Teemu, Silvennoinen, Olli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016850/
https://www.ncbi.nlm.nih.gov/pubmed/31892268
http://dx.doi.org/10.3390/cancers12010078
_version_ 1783497070411251712
author Raivola, Juuli
Haikarainen, Teemu
Silvennoinen, Olli
author_facet Raivola, Juuli
Haikarainen, Teemu
Silvennoinen, Olli
author_sort Raivola, Juuli
collection PubMed
description The Janus kinase-signal transducer and activator of transcription protein (JAK-STAT) pathway mediates essential biological functions from immune responses to haematopoiesis. Deregulated JAK-STAT signaling causes myeloproliferative neoplasms, leukaemia, and lymphomas, as well as autoimmune diseases. Thereby JAKs have gained significant relevance as therapeutic targets. However, there is still a clinical need for better JAK inhibitors and novel strategies targeting regions outside the conserved kinase domain have gained interest. In-depth knowledge about the molecular details of JAK activation is required. For example, whether the function and regulation between receptors is conserved remains an open question. We used JAK-deficient cell-lines and structure-based mutagenesis to study the function of JAK1 and its pseudokinase domain (JH2) in cytokine signaling pathways that employ JAK1 with different JAK heterodimerization partner. In interleukin-2 (IL-2)-induced STAT5 activation JAK1 was dominant over JAK3 but in interferon-γ (IFNγ) and interferon-α (IFNα) signaling both JAK1 and heteromeric partner JAK2 or TYK2 were both indispensable for STAT1 activation. Moreover, IL-2 signaling was strictly dependent on both JAK1 JH1 and JH2 but in IFNγ signaling JAK1 JH2 rather than kinase activity was required for STAT1 activation. To investigate the regulatory function, we focused on two allosteric regions in JAK1 JH2, the ATP-binding pocket and the αC-helix. Mutating L633 at the αC reduced basal and cytokine induced activation of STAT in both JAK1 wild-type (WT) and constitutively activated mutant backgrounds. Moreover, biochemical characterization and comparison of JH2s let us depict differences in the JH2 ATP-binding and strengthen the hypothesis that de-stabilization of the domain disturbs the regulatory JH1-JH2 interaction. Collectively, our results bring mechanistic understanding about the function of JAK1 in different receptor complexes that likely have relevance for the design of specific JAK modulators.
format Online
Article
Text
id pubmed-7016850
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70168502020-02-28 Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling Raivola, Juuli Haikarainen, Teemu Silvennoinen, Olli Cancers (Basel) Article The Janus kinase-signal transducer and activator of transcription protein (JAK-STAT) pathway mediates essential biological functions from immune responses to haematopoiesis. Deregulated JAK-STAT signaling causes myeloproliferative neoplasms, leukaemia, and lymphomas, as well as autoimmune diseases. Thereby JAKs have gained significant relevance as therapeutic targets. However, there is still a clinical need for better JAK inhibitors and novel strategies targeting regions outside the conserved kinase domain have gained interest. In-depth knowledge about the molecular details of JAK activation is required. For example, whether the function and regulation between receptors is conserved remains an open question. We used JAK-deficient cell-lines and structure-based mutagenesis to study the function of JAK1 and its pseudokinase domain (JH2) in cytokine signaling pathways that employ JAK1 with different JAK heterodimerization partner. In interleukin-2 (IL-2)-induced STAT5 activation JAK1 was dominant over JAK3 but in interferon-γ (IFNγ) and interferon-α (IFNα) signaling both JAK1 and heteromeric partner JAK2 or TYK2 were both indispensable for STAT1 activation. Moreover, IL-2 signaling was strictly dependent on both JAK1 JH1 and JH2 but in IFNγ signaling JAK1 JH2 rather than kinase activity was required for STAT1 activation. To investigate the regulatory function, we focused on two allosteric regions in JAK1 JH2, the ATP-binding pocket and the αC-helix. Mutating L633 at the αC reduced basal and cytokine induced activation of STAT in both JAK1 wild-type (WT) and constitutively activated mutant backgrounds. Moreover, biochemical characterization and comparison of JH2s let us depict differences in the JH2 ATP-binding and strengthen the hypothesis that de-stabilization of the domain disturbs the regulatory JH1-JH2 interaction. Collectively, our results bring mechanistic understanding about the function of JAK1 in different receptor complexes that likely have relevance for the design of specific JAK modulators. MDPI 2019-12-27 /pmc/articles/PMC7016850/ /pubmed/31892268 http://dx.doi.org/10.3390/cancers12010078 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Raivola, Juuli
Haikarainen, Teemu
Silvennoinen, Olli
Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
title Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
title_full Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
title_fullStr Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
title_full_unstemmed Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
title_short Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
title_sort characterization of jak1 pseudokinase domain in cytokine signaling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016850/
https://www.ncbi.nlm.nih.gov/pubmed/31892268
http://dx.doi.org/10.3390/cancers12010078
work_keys_str_mv AT raivolajuuli characterizationofjak1pseudokinasedomainincytokinesignaling
AT haikarainenteemu characterizationofjak1pseudokinasedomainincytokinesignaling
AT silvennoinenolli characterizationofjak1pseudokinasedomainincytokinesignaling